UTi Worldwide to Present at the Merrill Lynch Global Transportation Leaders Conference
RANCHO DOMINGUEZ, Calif., June 3, 2003 (PRIMEZONE) -- UTi Worldwide Inc. (Nasdaq:UTIW) today announced that it will present at the Merrill Lynch Global Transportation Leaders Conference on Wednesday, June 11, 2003, at 2:20 p.m. EDT, at the St. Regis Hotel in New York City.
GREENWICH, Conn., June 3, 2003 (PRIMEZONE) -- Blyth, Inc. (NYSE:BTH), a leader in home fragrance and decorative accents, today reported first quarter Net Sales of $312.0 million compared with $277.9 million a year earlier, an increase of 12%. Operating Profit for the first quarter was $34.3 million, an increase of 11% compared to $30.9 million in the prior year period. Net Earnings for the quarter increased 53% to $19.6 million versus $12.8 million a year earlier. Diluted Net Earnings Per Share for the first quarter were $0.42 per share compared to $0.28 per share for the same period last year, an increase of 50%. The increase in Net Earnings and Diluted Net Earnings Per Share is partly attributable to last year's adoption of SFAS 142, which reduced the carrying value of the goodwill related to the Company's 1997 acquisition of the Sterno(r) brand by $7.4 million as of February 1, 2002. This goodwill impairment was recorded as a cumulative effect of a change in accounting principle and reduced last year's first quarter net income by $4.5 million (after tax) or $0.10 per share. Excluding the effect of SFAS 142, last year's first quarter Earnings Per Share would have been $0.37.
Bruce Redditt Joins Scott Blum's Advisory Board for New Venture
SANTA MONICA, Calif., June 3, 2003 (PRIMEZONE) -- Scott Blum, whose third successful company Buy.com set the record for fastest growing company in U.S. history, today announced that Bruce Redditt -- Executive Vice President of the Omnicom Group -- has joined the Advisory Board for his upcoming direct response network, which includes the television show, BuyTV.
New Dates for Skandia's Interim Reports
STOCKHOLM, Sweden, June 3, 2003 (PRIMEZONE) -- Skandia's (Other OTC:SKNFF) (LSE:SDIAq) has set new dates for its forthcoming interim reports in 2003.
MTG Acquires Remaining Shares in TV3 Lithuania
STOCKHOLM, Sweden, June 3, 2003 (PRIMEZONE) -- Modern Times Group MTG AB (Nasdaq:MTGNY), the international media group, today announced that it has acquired the remaining 16 per cent of the shares in TV3 Lithuania, increasing its ownership to 100 percent. MTG owns 100% of TV3 in the other Baltic States of Estonia and Latvia.
Nordisk Renting Builds Industrial Bakery for the Food Corporation Cerealia for MSEK 155
STOCKHOLM, Sweden, June 3, 2003 (PRIMEZONE) -- Nordisk Renting AB has reached an agreement with Cerealia AB for acquisition and construction of a plant for production and distribution of bakery products in Umea worth a total of SEK 155 m. The building in question is being built by Finnish building group Lemminkainen's subsidiary Rekab, and Cerealia has signed a 20-year lease with Nordisk Renting.
Peab to Build New Cooperative Flats in Malmoe
FOERSLOEV, Sweden, June 3, 2003 (PRIMEZONE) -- Peab has won the contract to build 94 new cooperative flats at the Dockan area, close to the harbour in Malmoe. The client is JM and the contract amounts SEK 159 million. The general contract will start in June 2003 and it is supposed to be completed during the winter 2004-2005.
COMPASS GROUP -- 2003 Shareholder Conference
CHERTSEY, United Kingdom, June 3, 2003 (PRIMEZONE) -- Managing Future Growth -- Investor Presentations Webcast now available free on http://www.cantos.com featuring:
LONDON, June 3, 2003 (PRIMEZONE) -- Indepth interview now available free on http://www.cantos.com with Mike Clasper, Chief Executive Designate in video, audio and text.
Crucell Expands Relationship with Merck & Co.
LEIDEN, Netherlands, June 3, 2003 (PRIMEZONE) -- Dutch antibody and vaccine company Crucell N.V. (Euronext:CRXL) (Nasdaq:CRXL) announced today that it has expanded the Cooperation Agreement made with Merck & Co. Inc. which relates to the PER.C6(tm) Cell Substrate Biologics Master File (BMF), BB-MF 8453 in the United States of America, and equivalents in other jurisdictions. The BMF is the regulatory dossier filed with the Food & Drug Administration (FDA). Licensees of Crucell's PER.C6(tm) cell technology platform refer to this BMF for their regulatory filings of PER.C6(tm)-based products.
